Here are 3 high-quality shares on the S&P/ASX 100 I would buy today

CSL Limited (ASX:CSL) is one of three shares on the S&P/ASX 100 (Index:^AXTO) (ASX:XTO) which I think could be in the buy zone. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 100 (Index: ^AXTO) (ASX: XTO) is home to the top 100 listed companies in Australia.

Although a good number of these such as Woolworths Limited (ASX: WOW) and Westfield Corp Ltd (ASX: WFD) are perhaps best avoided, there are a few that jump out as being potential investments.

Three which I would consider today are listed below:

CSL Limited (ASX: CSL)

Although its share price may have rallied strongly this year, I don't believe it is too late to invest in this high-quality biotherapeutics company. Thanks to the success of its leading immunoglobulins business and its fledgling influenza vaccine business, I expect CSL to deliver strong earnings growth for at least the next five years. In my opinion this justifies its shares trading at around 30x trailing earnings.

Caltex Australia Limited (ASX: CTX)

While the loss of the Woolworths fuel contract was a big disappointment, I think the fuel retailer will bounce back strongly thanks to its cost cutting plan, volume growth, and the acquisition of the Milemaker retail fuel business. So with its shares trading at an undemanding 14x trailing earnings, Caltex could be worth a closer look today in my opinion.

Qantas Airways Limited (ASX: QAN)

I've been very bullish on this leading airline this year and can't say I'm surprised to see its shares up by 50% year-to-date. Despite these gains I think its shares could ride higher still over the next few months if oil prices remain favourable. Furthermore, at its investor day management revealed bold plans for the future. If it can deliver on them then Qantas will be in a great position to achieve above-average earnings growth for the next few years.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »